Skip to main content
Erschienen in: Clinical Rheumatology 4/2009

01.04.2009 | Original Article

Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies

verfasst von: Eiko Seki, Isao Matsushita, Eiji Sugiyama, Hirohumi Taki, Koichiro Shinoda, Hiroyuki Hounoki, Hiraku Motomura, Tomoatsu Kimura

Erschienen in: Clinical Rheumatology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to assess the influence of tumor necrosis factor (TNF)-blocking therapies on weight-bearing joints in patients with rheumatoid arthritis. Changes in clinical variables and radiological findings in 213 weight-bearing joints (69 hip joints, 63 knee joints, and 81 ankle joints) of 42 consecutive patients were investigated at baseline and at 1 year of TNF-blocking therapies. Structural damage to the weight-bearing joints was assessed using the Larsen scoring method. Detailed comparisons of the sizes and locations of erosions were performed for each set of radiographs of the respective joints. Assessment of radiographs of the 213 weight-bearing joints indicated progression of the Larsen grade in eight joints. Another five joints without Larsen grade progression showed apparent radiographic progression of joint damage based on increases in bony erosions. Overall, 13 joints (6%) of eight patients (19%) showed progression of joint damage after 1 year of TNF-blocking therapies. Analysis of each baseline grade indicated that radiographic progression of joint damage was inhibited in most grade 0–II joints. On the other hand, all hip and knee joints with pre-existing damage of grade III/IV showed apparent progression even in patients with good response. The results further suggested that radiographic progression may occur in less damaged joints when the patients were non-responders to the therapy. Among the weight-bearing joints, ankle joints showed different radiographic behavior and four ankle joints displayed improvement of radiographic damage. Early initiation of anti-TNF therapy should be necessary especially when the patients are starting to show early structural damage in weight-bearing joints.
Literatur
1.
Zurück zum Zitat Welsing PM, van Gestel AM, Swinkels HL et al (2001) The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 44:2009–2017PubMedCrossRef Welsing PM, van Gestel AM, Swinkels HL et al (2001) The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 44:2009–2017PubMedCrossRef
2.
Zurück zum Zitat Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593PubMedCrossRef Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593PubMedCrossRef
3.
Zurück zum Zitat Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594–1602PubMedCrossRef Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594–1602PubMedCrossRef
4.
Zurück zum Zitat Smolen JS, van der Heijde DM, St. Clair EW et al (2006) Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 54:702–710PubMedCrossRef Smolen JS, van der Heijde DM, St. Clair EW et al (2006) Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 54:702–710PubMedCrossRef
5.
Zurück zum Zitat Landewe R, van der Heijde D, Klareskog L et al (2006) Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 54:3119–3125PubMedCrossRef Landewe R, van der Heijde D, Klareskog L et al (2006) Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 54:3119–3125PubMedCrossRef
6.
Zurück zum Zitat Kuper HH, van Leeuwen MA, van Riel PL et al (1997) Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability. Br J Rheumatol 36:855–860PubMedCrossRef Kuper HH, van Leeuwen MA, van Riel PL et al (1997) Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability. Br J Rheumatol 36:855–860PubMedCrossRef
7.
Zurück zum Zitat Drossaers-Bakker KW, Kroon HM, Zwinderman AH et al (2000) Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function. Rheumatology 39:998–1003PubMedCrossRef Drossaers-Bakker KW, Kroon HM, Zwinderman AH et al (2000) Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function. Rheumatology 39:998–1003PubMedCrossRef
8.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
9.
Zurück zum Zitat Miyasaka N, Takeuchi T, Eguchi K (2005) Official Japanese guidelines for the use of infliximab for rheumatoid arthritis. Mod Rheumatol 15:4–8PubMedCrossRef Miyasaka N, Takeuchi T, Eguchi K (2005) Official Japanese guidelines for the use of infliximab for rheumatoid arthritis. Mod Rheumatol 15:4–8PubMedCrossRef
10.
Zurück zum Zitat Miyasaka N, Takeuchi T, Eguchi K (2006) Guidelines for the proper use of etanercept in Japan. Mod Rheumatol 16:63–67PubMedCrossRef Miyasaka N, Takeuchi T, Eguchi K (2006) Guidelines for the proper use of etanercept in Japan. Mod Rheumatol 16:63–67PubMedCrossRef
11.
Zurück zum Zitat Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481–491 Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481–491
12.
Zurück zum Zitat Guth A, Coste J, Chagnon S et al (1995) Reliability of three methods of radiologic assessment in patients with rheumatoid arthritis. Invest Radiol 30:181–185PubMedCrossRef Guth A, Coste J, Chagnon S et al (1995) Reliability of three methods of radiologic assessment in patients with rheumatoid arthritis. Invest Radiol 30:181–185PubMedCrossRef
13.
Zurück zum Zitat Scott DL, Laasonen L, Priolo F et al (1997) The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol 15(Suppl 17):S53–S61PubMed Scott DL, Laasonen L, Priolo F et al (1997) The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol 15(Suppl 17):S53–S61PubMed
14.
Zurück zum Zitat Rau R, Wassenberg S, Herborn G et al (2001) Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheum 28:2608–2615PubMed Rau R, Wassenberg S, Herborn G et al (2001) Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheum 28:2608–2615PubMed
15.
Zurück zum Zitat Ideguchi H, Ohno S, Hattori H et al (2006) Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res 8:R76CrossRef Ideguchi H, Ohno S, Hattori H et al (2006) Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res 8:R76CrossRef
16.
Zurück zum Zitat van der Heijde DM, van’t Hof MA, van Riel PL et al (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920PubMedCrossRef van der Heijde DM, van’t Hof MA, van Riel PL et al (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920PubMedCrossRef
17.
Zurück zum Zitat Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
18.
Zurück zum Zitat van Gestel AM, Prevoo ML, van’t Hof MA et al (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34–40PubMedCrossRef van Gestel AM, Prevoo ML, van’t Hof MA et al (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34–40PubMedCrossRef
19.
Zurück zum Zitat Kaufmann J, Kielstein V, Kilian S et al (2003) Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 30:2350–2355PubMed Kaufmann J, Kielstein V, Kilian S et al (2003) Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 30:2350–2355PubMed
20.
Zurück zum Zitat van der Helm-van Mil AH, van der Kooij SM, Allaart CF et al (2008) A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 67:769–774PubMedCrossRef van der Helm-van Mil AH, van der Kooij SM, Allaart CF et al (2008) A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 67:769–774PubMedCrossRef
21.
Zurück zum Zitat Keystone EC, Kavanaugh AF, Sharp JT et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400–1411PubMedCrossRef Keystone EC, Kavanaugh AF, Sharp JT et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400–1411PubMedCrossRef
22.
Zurück zum Zitat Breedveld FC, Weisman MH, Kavanaugh AF et al (2006) The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26–37PubMedCrossRef Breedveld FC, Weisman MH, Kavanaugh AF et al (2006) The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26–37PubMedCrossRef
23.
Zurück zum Zitat Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52:3381–3390PubMedCrossRef Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52:3381–3390PubMedCrossRef
24.
Zurück zum Zitat Munneke M, de Jong Z, Zwinderman AH et al (2005) Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. Arthritis Rheum 53:410–417PubMedCrossRef Munneke M, de Jong Z, Zwinderman AH et al (2005) Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. Arthritis Rheum 53:410–417PubMedCrossRef
25.
Zurück zum Zitat Shay AK, Bliven ML, Scampoli DN et al (1995) Effects of exercise on synovium and cartilage from normal and inflamed knees. Rheumatol Int 14:183–189PubMedCrossRef Shay AK, Bliven ML, Scampoli DN et al (1995) Effects of exercise on synovium and cartilage from normal and inflamed knees. Rheumatol Int 14:183–189PubMedCrossRef
26.
Zurück zum Zitat Akagi S, Sugano H, Ogawa R (1997) The long-term results of ankle joint synovectomy for rheumatoid arthritis. Clin Rheum 16:284–290CrossRef Akagi S, Sugano H, Ogawa R (1997) The long-term results of ankle joint synovectomy for rheumatoid arthritis. Clin Rheum 16:284–290CrossRef
27.
Metadaten
Titel
Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies
verfasst von
Eiko Seki
Isao Matsushita
Eiji Sugiyama
Hirohumi Taki
Koichiro Shinoda
Hiroyuki Hounoki
Hiraku Motomura
Tomoatsu Kimura
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 4/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-1076-9

Weitere Artikel der Ausgabe 4/2009

Clinical Rheumatology 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.